Viral suppression in adults on efavirenz- or dolutegravir-based antiretroviral therapy in Mopani District, South Africa
TLD showed improved suppression compared to TEE at 6 but not 12 months. The high proportion of clients with low-level viraemia is concerning. All clients, regardless of regimen, need evaluation for adherence support.
Authors
- Barry Mutasa (ORCID: https://orcid.org/0000-0002-8670-3852)
- Christine Njuguna (ORCID: https://orcid.org/0000-0001-8710-2824)
- Lucia Hans (ORCID: https://orcid.org/0000-0002-0330-4857)
- Kate Rees (ORCID: https://orcid.org/0000-0002-0584-0557)
- Natasha Davies (ORCID: https://orcid.org/0000-0002-0587-0326)
- Christina Maluleke (ORCID: https://orcid.org/0000-0001-7584-0723)
Institutions
- National Health Laboratory Service (ZA)
- University of the Witwatersrand (ZA)
- Anova Health Institute (ZA)
Publication Details
- Journal
- Southern African Journal of HIV Medicine
- Published
- 2025-08-28
- DOI
- https://doi.org/10.4102/sajhivmed.v26i1.1718
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00